Founded in 2020 and based in Copenhagen, Scandinavian Biolabs develops science-backed, non-invasive preventative products targeting early-stage hair loss. Its flagship product, the Bio-Pilixin® Activation Serum, has been clinically tested and is central to the company’s offering. SBL launched as a direct-to-consumer brand and has since expanded into retail and various pharmacies. The company reports supporting over 140,000 customers and holds a 4.5 out of 5 Trustpilot score. Future plans include scaling the online business, expanding strategic retail (including pharmacies), leading in the UK, Germany and the Nordics, and entering the US market, with SevenVentures supporting German expansion via a strategic TV collaboration. SBL positions itself as a preferred solution for reliable, tested hair-care products that work with the body.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2024